Connor, Clark & Lunn Investment Management (CC&L)’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
OCAM
HCL
SCM
BCC
QF
JCP
Connor, Clark & Lunn Investment Management (CC&L)'s ATEX Position: Q3 2022 in Review
Connor, Clark & Lunn Investment Management (CC&L) sold out of Anterix (ATEX) in Q3 2022, closing a stake of 5,169 shares — an estimated $212K sold.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ATEX in Q1 2021 and held it in 6 quarters. The position peaked at $754K in Q2 2021. 100 funds tracked by Wall St. Rank hold ATEX as of Q3 2022.
- Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Anterix position as of Q3 2022 after selling out during the quarter.
- Connor, Clark & Lunn Investment Management (CC&L) sold 5,169 Anterix shares in Q3 2022, an estimated $212K.
- Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Anterix in Q1 2021 and held it in 6 quarters.
- Connor, Clark & Lunn Investment Management (CC&L)'s Anterix position peaked at $754K in Q2 2021.
- 100 funds tracked by Wall St. Rank held Anterix as of Q3 2022.
Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2022, filed 10 Nov 2022.